Wojcicki Janet M, Geissler Jillian D, Stokes Christina W, Heyman Melvin B, Tran C T
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of California, San Francisco, CA 94134, USA.
High Blood Press Cardiovasc Prev. 2013 Jun;20(2):89-92. doi: 10.1007/s40292-013-0014-3. Epub 2013 May 8.
The RESPeRATE device was tested for feasibility of use in a population of overweight and obese children and adolescents (n = 10) in San Francisco, CA. After a 2-week and then a 2-month period, participants were interviewed on their frequency of use and attitudes towards the device. A high percentage stated that they enjoyed using the device at 2 months (90%) and 80% stated that they would recommend use to a friend or relative. Future studies are needed to assess the efficacy of the RESPeRATE device in lowering blood pressure and helping with weight loss/weight management in obese and overweight children.
在加利福尼亚州旧金山，对超重和肥胖儿童及青少年群体（n = 10）测试了RESPeRATE设备的使用可行性。在为期2周然后为期2个月的时间段后，就参与者对该设备的使用频率和态度进行了访谈。很大比例的人表示在2个月时他们喜欢使用该设备（90%），80%的人表示他们会向朋友或亲戚推荐使用。需要开展进一步研究来评估RESPeRATE设备在降低肥胖和超重儿童血压以及帮助减肥/体重管理方面的效果。
